For the past two decades, my research, supported by NINDS and NIDA, has been focused on understanding the cellular mechanisms of dopamine transmission in both healthy and diseased conditions, including drug addiction, neuropsychiatric disorders, and neurodegenerative diseases. A major challenge in treating disorders where brain dopamine levels are dysregulated is identifying the precise molecular mechanisms involved and developing targeted therapies to address them.
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Economist Chris Richardson on an ‘ugly’ inflation result and the coming budget
Why Germany ditched nuclear before coal – and why it won’t go back
Labour can afford to be far more ambitious with its economic policies – voters are on board
Sudan: civil war stretches into a second year with no end in sight